Literature DB >> 4479295

The biotransformation of cyclophosphamide in man: influence of prednisone.

O K Faber, H T Mouridsen, L Skovsted.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4479295     DOI： 10.1111/j.1600-0773.1974.tb00739.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  8 in total

Review 1.  Metabolism and pharmacokinetics of oxazaphosphorines.

Authors:  A V Boddy; S M Yule
Journal:  Clin Pharmacokinet       Date:  2000-04       Impact factor: 6.447

2.  Disposition of antipyrine in African patients with Hodgkin's lymphoma.

Authors:  F D Juma
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

3.  The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion.

Authors:  A V Boddy; M Cole; A D Pearson; J R Idle
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation.

Authors:  Nuala A Helsby; Chung-Yee Hui; Michael A Goldthorpe; Janet K Coller; May Ching Soh; Peter J Gow; Janak Z De Zoysa; Malcolm D Tingle
Journal:  Br J Clin Pharmacol       Date:  2010-12       Impact factor: 4.335

5.  Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients.

Authors:  M J Tasso; A V Boddy; L Price; R A Wyllie; A D Pearson; J R Idle
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.

Authors:  Michael J Dolton; John E Ray; Sharon C-A Chen; Kingsley Ng; Lisa G Pont; Andrew J McLachlan
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

Review 7.  Antineoplastic agents. Drug interactions of clinical significance.

Authors:  E van Meerten; J Verweij; J H Schellens
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

Review 8.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  Milly E de Jonge; Alwin D R Huitema; Sjoerd Rodenhuis; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.